A detailed history of Prudential Financial Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 123,220 shares of ORGO stock, worth $494,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123,220
Previous 120,420 2.33%
Holding current value
$494,112
Previous $337,000 4.45%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.42 - $3.24 $6,776 - $9,072
2,800 Added 2.33%
123,220 $352,000
Q2 2024

Aug 13, 2024

BUY
$2.28 - $3.03 $4,104 - $5,454
1,800 Added 1.52%
120,420 $337,000
Q1 2024

May 14, 2024

BUY
$2.61 - $4.49 $200,448 - $344,832
76,800 Added 183.64%
118,620 $336,000
Q4 2023

Feb 13, 2024

SELL
$1.97 - $4.21 $63,040 - $134,720
-32,000 Reduced 43.35%
41,820 $171,000
Q3 2023

Nov 13, 2023

SELL
$2.34 - $4.43 $74,646 - $141,317
-31,900 Reduced 30.17%
73,820 $234,000
Q2 2023

Aug 11, 2023

SELL
$1.9 - $4.3 $545,015 - $1.23 Million
-286,850 Reduced 73.07%
105,720 $350,000
Q1 2023

May 12, 2023

SELL
$1.89 - $2.93 $197,760 - $306,580
-104,635 Reduced 21.04%
392,570 $836,000
Q4 2022

Feb 14, 2023

BUY
$2.48 - $3.43 $57,784 - $79,919
23,300 Added 4.92%
497,205 $0
Q3 2022

Nov 04, 2022

BUY
$3.14 - $6.43 $86,978 - $178,111
27,700 Added 6.21%
473,905 $1.54 Million
Q2 2022

Aug 15, 2022

SELL
$4.74 - $8.15 $378,768 - $651,258
-79,909 Reduced 15.19%
446,205 $2.18 Million
Q1 2022

May 13, 2022

SELL
$6.47 - $9.57 $384,098 - $568,132
-59,366 Reduced 10.14%
526,114 $4.01 Million
Q4 2021

Feb 14, 2022

SELL
$9.02 - $13.5 $43,602 - $65,259
-4,834 Reduced 0.82%
585,480 $5.41 Million
Q3 2021

Nov 15, 2021

SELL
$13.71 - $17.18 $48,355 - $60,593
-3,527 Reduced 0.59%
590,314 $8.41 Million
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $1.36 Million - $2.12 Million
91,421 Added 18.2%
593,841 $9.87 Million
Q1 2021

May 12, 2021

BUY
$7.33 - $21.06 $3.68 Million - $10.6 Million
502,420 New
502,420 $9.16 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $525M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.